Dietary fats and insulin action L. H. StorlienL. A. BaurL. V. Campbell Review 01 June 1996 Pages: 621 - 631
Effects of early insulin treatment on ultrastructural changes of glomeruli in diabetic rats revealed by the quick-freezing and deep-etching method T. MoriyaS. OhnoY. Yajima Originals 01 June 1996 Pages: 632 - 640
Effect of an aldose reductase inhibitor on type IV collagen production by human endothelial cells cultured in high glucose A. BakillahA. M. Grigorova-BorsosM. Sternberg Originals 01 June 1996 Pages: 641 - 648
Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats H. MulderB. AhrénF. Sundler Originals 01 June 1996 Pages: 649 - 657
Presence of sulphatide (3′-sulphogalactosylceramide) in pericytes in the choroid layer of the eye: sharing of this glycolipid autoantigen with islets of Langerhans K. BuschardT. HornP. Fredman Originals 01 June 1996 Pages: 658 - 666
Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins E. DimitriadisM. GriffinG. R. Tomkin Originals 01 June 1996 Pages: 667 - 676
Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia S. PampanelliC. FanelliG. B. Bolli Originals 01 June 1996 Pages: 677 - 686
C-peptide improves autonomic nerve function in IDDM patients B. L. JohanssonK. BorgJ. Wahren Originals 01 June 1996 Pages: 687 - 695
Aortic atherosclerosis in diabetes mellitus is associated with an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene L. M. RasmussenT. Ledet Originals 01 June 1996 Pages: 696 - 700
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients S. KumarA. J. M. BoultonThe Troglitazone study group Originals 01 June 1996 Pages: 701 - 709
Socioeconomic and behavioural risk factors for mortality of individuals with IDDM in Japan: population-based case-control study M. MatsushimaK. ShimizuThe Diabetes Epidemiology Research International (DERI) US-Japan Mortality Study Group Originals 01 June 1996 Pages: 710 - 716
Abnormal Na+/H+ antiport activity in cultured fibroblasts from NIDDM patients with hypertension and microalbuminuria R. TrevisanM. R. CipollinaR. Nosadini Originals 01 June 1996 Pages: 717 - 724
Searching for NIDDM susceptibility genes: studies of genes with triplet repeats expressed in skeletal muscle K. YamagataJ. TakedaG. I. Bell Originals 01 June 1996 Pages: 725 - 730
Infusion of pH 2.0 d-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycaemia M. C. FontelesL. C. HuangJ. Larner Rapid Communications 01 June 1996 Pages: 731 - 734
Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats S. RoyM. Lorenzi Rapid Communications 01 June 1996 Pages: 735 - 738
Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes M. Porta For Debates 01 June 1996 Pages: 739 - 744
Endothelium: the main actor or choreographer in the remodelling of the retinal microvasculature in diabetes? J. E. Tooke For Debates 01 June 1996 Pages: 745 - 746
Islet cell autoantigen 69 antibodies in IDDM S. Martin Letter to the Editors 01 June 1996 Pages: 747 - 747
Internal marker for quantitative analysis of mRNA by reverse transcriptase-polymerase chain reaction in pancreatic beta cells E. Yamato Letter to the Editors 01 June 1996 Pages: 747 - 748